A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 9, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2026

Conditions

Pancreatic Cancer Non-resectable

Interventions

BIOLOGICAL

chemotherapy sequential CAR-NK cell infusion

In each chemotherapy cycle, patients received 2 intravenous infusions of CAR-NK on days 2 and 3 after each chemotherapy was discontinued.

Trial Locations (1)

RECRUITING

the first affiliated hospital of Zhejiang University，school of medicine, Hangzhou

All Listed Sponsors

lead

Zhejiang University

OTHER